By proceeding, you agree to our Terms of Use and Privacy Policy.
Previously, Michele was the head of Litigation and Intellectual Property at Human Genome Sciences (HGS). She created and managed all aspects of HGS’ extensive IP portfolio in the U.S.
Talks About #litigation #internalinvestigations
Preferred Locations #NorthAmerica
Phage therapies have shown promise in compassionate use, but limited success of double blind randomised controlled trials has slowed progression through the clinic.
From A-Z of phage development, the 5th Bacteriophage Therapy Summit is the definitive commercial-orientated conference to accelerate phage-based applications for organizations pioneering with phage pipelines.
